跳至主要内容
临床试验/NCT01238419
NCT01238419已完成4 期

Clinical Assessment of Physiotulle Dressing Compared to Urgotul Dressing in the Treatment of Leg Ulcer

Coloplast A/S63 个研究点 分布在 2 个国家目标入组 188 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Coloplast A/S
入组人数
188
试验地点
63
主要终点
pain at dressing removal

研究概览

简要总结

The aim of this study is to assess the pain at removal of Physiotulle dressing in comparison with that of Urgotul dressing in patients presenting a venous (or predominantly) venous leg ulcer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient of either sex over 18 who have not been declared legally incompetent and who having given his written informed consent
  • Patient with venous or predominantly venous leg ulcer (ankle-brachial index > 0.8)
  • Patient with venous or predominantly venous leg ulcer in granulation phase (granulation tissue > 70 %)
  • Patient with venous or predominantly venous leg ulcer with low exsudate
  • Patient with venous or predominantly venous leg ulcer with a wound surface between 4 cm² and 170 cm²
  • Patient with venous or predominantly venous leg ulcer that has been treated with an appropriate compression in the two weeks prior to inclusion
  • Patient available to be monitored for at least 4 weeks
  • Patient able to answer questionnaires and particularly to evaluate his pain

排除标准

  • Patient whose leg ulcer is locally infected (At least 3 of 5 clinical signs suggestive of infection *)* 5 signs suggestive of infection: pain, exsudate, smell, oedema, erythema
  • Patient requiring an analgesic treatment for the care (before dressing removal)
  • Patient whose ulcer belongs to angiodermatitis type or demonstrates a vasculitis
  • Patient with arterial ulcer
  • Patient with purely traumatic, infectious or neoplastic origin ulcer
  • Patient with a diabetic neuropathy of lower limbs
  • Patient with a known allergy to one of Physiotulle or Urgotul components
  • Patient already participating in another clinical study
  • Pregnant or breastfeeding patient
  • Patient who have been taking corticoids > 10mg / day or cytostatics by systematic way for the three months prior to inclusion
  • Patient who have undergone surgery of saphenous trunk in the two months prior to inclusion

结局指标

主要结局

pain at dressing removal

时间窗: 4 weeks

pain at dressing removal assessed by the patient immediately after dressing removal on a VAS scale

次要结局

  • Relative reduction of the area of the leg ulcer measured by planimetry at final point at week 4 compared to the area at inclusion(4weeks)
  • Number of patients with adverse events as a measure of safety and tolerability(4 weeks)

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (63)

Loading locations...

相似试验